Skip to main content

Advertisement

Fig. 2 | Arthritis Research & Therapy

Fig. 2

From: miR-155 in the progression of lung fibrosis in systemic sclerosis

Fig. 2

Whole lung homogenate with miRNA and mRNA expression by qPCR of miR-182 (a), miR-155 (b), miR-21 (c), collagen type 3 alpha-1 (Col3a1) (d), MS4A4A (e), and periostin (POSTN) (f) in healthy controls (HC) (n = 5) and patients with systemic sclerosis interstitial lung disease (SSc-ILD) (n = 14). Data are expressed as fold-change normalized to miRNA (RNU6B) or mRNA (18S) average expression in HC samples. Student’s t test; p < 0.05 was considered significant

Back to article page